SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Leerink Partners Raises Replimune Price Target to $31 From $19

Leerink Partners maintained its Outperform rating and raised its price target from $19 to $31.

REPL

Related stories